The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling

Area of Science:

• Molecular Biology
• Immunology
• Cell Signaling

Background:

• CARMA proteins are key regulators of NF-κB signaling.
• Mutations in CARMA2 are linked to psoriasis susceptibility.
• NF-κB is a pro-inflammatory transcription factor crucial in immune responses.

Purpose of the Study:

• To identify novel regulators of CARMA2 function.
• To elucidate the mechanism by which CARMA2 activates NF-κB.
• To understand the role of CARMA2 regulation in psoriasis.

Main Methods:

• Yeast two-hybrid screening to identify protein interactors.
• Western blotting and ubiquitination assays to assess protein modifications.
• Analysis of NF-κB activation in cellular models.

Main Results:

• RNF7 was identified as a CARMA2 interactor.
• RNF7 acts as a negative regulator of CARMA2-mediated NF-κB activation.
• RNF7 regulates the ubiquitination of MALT1 and NEMO.
• Psoriasis-associated CARMA2 mutants escape RNF7-mediated inhibition.

Conclusions:

• RNF7 provides a novel regulatory mechanism for CARMA2 activity.
• Dysregulation of RNF7-CARMA2 interaction may contribute to psoriasis pathogenesis.
• Understanding this pathway offers potential therapeutic targets for psoriasis.